Amazon certainly wasn’t the first major corporation to arrive at the cannabis reform party, but it sure made one of the biggest entrances to-date when it publicly pledged to relax its drug testing policies and also to back federal legalization efforts.
And now it’s a question of how many others will follow — especially during a time when some firms are desperate for workers.
Amazon (AMZN) kicked off June with an announcement that it would stop testing for cannabis metabolites as part of its drug screening program for positions not regulated by the US Department of Transportation. The company also said it would back the federal Marijuana Opportunity Reinvestment and Expungement (MORE) Act, a recently reintroduced bill aimed at descheduling marijuana and reassessing some past cannabis-related convictions.
– Read the entire article at CNN News.
